title: Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.
authors.affiliation: Department of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Second Medical University, Shanghai, China. yantfk@online.sh.cn
authors.forename: Jing Yan
authors.initials: JY
authors.lastname: Tang
authors.forename: Ci
authors.initials: C
authors.lastname: Pan
authors.forename: Jing
authors.initials: J
authors.lastname: Chen
authors.forename: Hongjun
authors.initials: H
authors.lastname: Chen
authors.forename: Yue
authors.initials: Y
authors.lastname: Wu
authors.forename: Huiliang
authors.initials: H
authors.lastname: Xue
authors.forename: HuiJun
authors.initials: H
authors.lastname: Zhao
authors.forename: Long Jun
authors.initials: LJ
authors.lastname: Gu
authors.forename: Ren Yi
authors.initials: RY
authors.lastname: Fu
authors.forename: Yao Ping
authors.initials: YP
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002681:China; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007223:Infant; D016393:Lymphoma, B-Cell / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D015080:Mesna; D007069:Ifosfamide; D011241:Prednisone; D008727:Methotrexate